MedTrace Logo

Benign Prostatic Hyperplasia (BPH) Mobile Application Pilot Study

NCT03228485 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-05-18

No results posted yet for this study

Summary

This study assesses the feasibility, and acceptability of a (mobile) application for men presenting at their physician's office with LUTS/BPH; starting with medical therapy and naïve for treatment. Patients will be enrolled in the study by their physician (GP or urologist). The patients will receive a daily medication reminder including frequent feedback on medication adherence. Furthermore, standard questionnaires will be filled out via the application. The hypothesis of this pilot study is that application is feasible and accepted in this group of patients.

Conditions

  • Prostatic Hyperplasia
  • Lower Urinary Tract Symptoms

Interventions

DEVICE

MyBPH Care mobile app

The application that will give daily medication reminders and via which the questionnaires can be filled out.

Sponsors & Collaborators

  • Société Internationale d'Urologie

    lead OTHER

Principal Investigators

  • Stavros Gravas, MD · Societe Internationale d'Urologie

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-04
Primary Completion
2023-01-31
Completion
2023-03-01

Countries

  • Greece
  • Italy
  • Portugal
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03228485 on ClinicalTrials.gov